logo

For the Inventor, By the Inventor

Albuquerque, NM, United States of America

Carlee Erin Ashley

This inventor holds 6 USPTO granted patents and 13 published patent applications. Top assignees: Sandia Corporation, The University of New Mexico. Active years: 2014-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carlee Erin Ashley. Retrieved from https://idiyas.com/inventor/carlee-erin-ashley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 83.3

Average Co-Inventor Count = 5.1

ph-index = 5

Forward Citations = 91(Granted Patents)


Company Filing History:

goldMedal6 out of 1,769 
 
Sandia Corporation
 patents
silverMedal6 out of 943 
 
The University of New Mexico
 patents
where one patent can have more than one assignee

Years Active: 2014-2018

Loading Chart...
6 patents (USPTO):Explore Patents
1. 10022327 - Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same (2018-07-17),
2. 9579283 - Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same (2017-02-28),
3. 9549976 - Affinity selection of Nipah and Hendra virus-related vaccine candidates from a complex random peptide library displayed on bacteriophage virus-like particles (2017-01-24),
4. 9480653 - Protocells and their use for targeted delivery of multicomponent cargos to cancer cells (2016-11-01),
5. 8992984 - Protocells and their use for targeted delivery of multicomponent cargos to cancer cells (2015-03-31),
6. 8734816 - Porous nanoparticle supported lipid bilayer nanostructures (2014-05-27),

Title: Carlee Erin Ashley: Innovator in Cancer Treatment Technologies

Introduction

Carlee Erin Ashley is a prominent inventor based in Albuquerque, NM, known for his significant contributions to cancer treatment technologies. With a total of six patents to his name, Ashley has focused on developing innovative solutions for targeted drug delivery systems.

Latest Patents

One of Ashley's latest patents is titled "Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same." This invention is designed for the specific targeting of hepatocellular and other cancer cells. It comprises a nanoporous silica core with a supported lipid bilayer, along with agents that facilitate cancer cell death. These agents may include traditional small molecules, macromolecular cargo such as siRNA, or protein toxins. The protocells are engineered to enhance the delivery of therapeutic agents directly to cancer cells, particularly hepatocellular tissue, using novel binding peptides.

Career Highlights

Throughout his career, Carlee Erin Ashley has worked with notable organizations, including Stc.unm and Sandia Corporation. His work has focused on advancing the field of cancer treatment through innovative research and development.

Collaborations

Ashley has collaborated with esteemed colleagues such as Eric C Carnes and C Jeffrey Brinker, contributing to the advancement of cancer treatment technologies.

Conclusion

Carlee Erin Ashley's innovative work in developing protocells for targeted cancer therapy showcases his commitment to improving treatment options for patients. His contributions to the field are paving the way for more effective cancer treatments and drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…